MRK

40 Upgrades and Downgrades for this Week

It pays to stay on top of the latest profit opportunities, and today's post is a great place to start. Here are Portfolio Grader's latest stock updates More 

10 Biotech Stocks With Symptoms of Strong Growth

Most sectors are overextended and ripe for weakness, but biotech stocks are the exception. Put these names on your list of stocks to buy this summer. More 

President Hillary Clinton: The U.S. Economy’s Winners and Losers

Could we end up seeing a President Hillary Clinton? If so, these are a few of the consequences it could have for the U.S. economy and Wall Street. More 

41 Trades To Make Before May Ends

During these times it pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start with these 41 trades More 

Keytruda: New Melanoma Drug Shows Promise

Keytruda is the name of a new melanoma drug by Merck that is helping to keep a little over 40% of patients alive for at least three years. More 

6 Pharmaceuticals Stocks to Sell Now

The ratings of 6 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

88 Blue Chip Stocks to Consider This Week

During these times it pays to stay on top of profit opportunities. Today's post is a great place to start with these latest Portfolio Grader ratings More